8 results
Clostridium Dificile Risk by Antibiotic Class

Pooled and study-specific risk estimates of community-associated CDI risk by antibiotic
Clostridium Dificile ... Risk by Antibiotic ... #CDifficile #Infection ... #Pharmacology # ... #Clostridium #Table
Equianalgesic Opioid Dosing 

#Pharmacology #Pain #Opioid #Opiate #Conversion #Equianalgesic #Table
Equianalgesic Opioid Dosing ... #Pharmacology ... #Pain #Opioid # ... Opiate #Conversion ... Equianalgesic #Table
Transdermal Fentanyl require unique dosing conversions. For Adult and pediatric patients taking opiouds or doses not
require unique dosing ... conversions. ... Then using Table ... #Pharmacology #Pain ... Opiate #Opioid #Conversion
Pain Assessment and Management Initiative (PAMI) - Opioid Prescribing and Equianalgesic Chart - Agents and Dosing

#Management
Pain Assessment ... #Pharmacology # ... Equianalgesics #Conversion ... #Doses #Dosing ... #Table #PAMI
Anti-infective stewardship, including tips for using anti-infectives wisely, criteria for stepdown from IV to PO dosage
including tips for using ... anti-infectives ... dosage forms and conversion ... #pharmacology #antibiotics ... #medications #table
IDSA 2017 CDiff Guidelines - TableĀ 7. Potential Treatment Agents for Treatment of the Primary Clostridium difficile
CDiff Guidelines - Table ... infection Episode ... #Pharmacology ... #Clostridium #CDifficile ... IDSA2017 #Adjunct #Antibiotics
GLP-1 Agonists

Adlyxin (Lixisenatide) Daily
Bydureon (Exenatide ER) Weekly 
Ozempic (Semaglutide) Weekly 
Trulicity (Dulaglutide) Weekly 
Victoza (Liraglutide) Daily
GI tract) and injection ... site pain. --- ... GLP1 #Agonists #Pharmacology ... #Dosing #Diabetes ... #DM2 #Endocrinology
Rybelsus (oral semaglutide) - First Oral GLP-1 Agonist
Dosing:
3 mg daily x 30 days, then 7 mg
GLP-1 Agonist Dosing ... oral route by using ... drug to remain stable ... semaglutide #Diabetes #Pharmacology ... #Endocrinology